NVG308 · Development Roadmap

Development Roadmap

Future Development Roadmap

👨

Human Products

Prescription Drugs

Purpose & Application :Development of prescription drugs for the prevention and treatment of influenza virus infection

·Prevention and treatment of type A and B influenza infections
·Treatment of influenza patients infected with Oseltamivir- and NA-inhibitor-resistant viruses
·Treatment of severe influenza patients who develop illness after influenza vaccination

Over-the-Counter (OTC) Drugs

Purpose & Application :Development of over-the-counter drugs for the prevention and treatment of influenza virus infection

·Based on preclinical and clinical results of the innovative antibody NVG308, compliant with each country's FDA guidelines
·Various administration routes: oral, inhalation, and injection

Quasi-drugs / Industrial

Purpose & Application :Production of industrial enzymes through advanced material optimization of the NVG308 innovative antibody

·Industrial enzyme production through advanced optimization of innovative antibody NVG308 materials
·Global standard for nucleic acid hydrolase in accordance with the revised EU LMO law

🐄

Prescription / OTC / Biosecurity Products

Purpose & Application :Developable as pharmaceuticals and biosecurity products for prevention and treatment of animal influenza viruses

·Birds (Wild Birds, Poultry): Avian Influenza (H5N1, H7N9, H5N6, etc.)
·Livestock (Live stocks): Swine Influenza (H1N1), Porcine Epidemic Diarrhea (PED), African Swine Fever (ASFV), Equine Influenza (H7N7, H3N8)
·Companion Animals: Canine Influenza (H3N8), Cat Influenza (H1N1)

Functional Foods and Dietary Supplements

Purpose & Application :Development of functional feed and supplementary feed products through mass production system for NVG308 innovative antibody